Vaxcyte (PCVX) Change in Acquisitions & Divestments (2021 - 2026)

Vaxcyte (PCVX) has 6 years of Change in Acquisitions & Divestments data on file, last reported at $24.9 million in Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $24.9 million, down 94.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$238.9 million (down 147.87% YoY), and the FY2025 annual result was $174.7 million, up 160.89% from the prior year.
• Change in Acquisitions & Divestments eased to $24.9 million in Q1 2026 per PCVX's latest filing, from $68.2 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $853.8 million in Q3 2024 and troughed at -$802.7 million in Q4 2024.
• A 5-year average of $61.6 million and a median of $24.9 million in 2026 frame the typical range for Change in Acquisitions & Divestments.
• On a YoY basis, Change in Acquisitions & Divestments climbed as much as 13298.57% in 2024 and fell as far as 233.1% in 2024.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $158.2 million in 2022, then jumped by 281.24% to $603.1 million in 2023, then tumbled by 233.1% to -$802.7 million in 2024, then jumped by 108.5% to $68.2 million in 2025, then plunged by 63.53% to $24.9 million in 2026.
• Business Quant data shows PCVX's Change in Acquisitions & Divestments at $24.9 million in Q1 2026, $68.2 million in Q4 2025, and -$726.5 million in Q3 2025.